# FAPI PET for Lung Fibrosis

> **NCT05365802** · EARLY_PHASE1 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 30 (estimated)

## Conditions studied

- Interstitial Lung Disease
- Idiopathic Interstitial Pneumonias
- Drug-Induced Pneumonitis
- Hypersensitivity Pneumonitis
- Radiation Pneumonitis
- Pneumoconiosis
- Pulmonary Fibrosis

## Interventions

- **DRUG:** 68Ga-FAPi-46
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** High Resolution Computed Tomography

## Key facts

- **NCT ID:** NCT05365802
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-16
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05365802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05365802, "FAPI PET for Lung Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05365802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*